Ranbaxy Laboratories Limited is an Indian company incorporated in 1961. It is India's largest pharmaceutical company. It exports its products to 125 countries with ground operations in 46 and manufacturing facilities in seven countries. It is ranked among the top 10 generic companies worldwide. Ranbaxy went public in 1973.
Having look on company's formation chart and date of listing chart, Ganesha feels that during the next few weeks company may have new overseas venture. Company shall make a new brand of product because of the conjunction of Saturn and Neptune in Leo Navamansha. But, this conjunction may have adverse effect on price projection of company in BSE and NSE.
Intraday price movement as on 21/11/2007
| PRICE CHANGE
Company has started declining since May 02, 2006. Long term and short term cycles were very poor for investors. The all-time high 639.71 has been made on December 31, 2004 during the transit of Jupiter over Natal Mars from first house. But, here Ganesha observes that during the year 2008 Jupiter will be transiting from its fifth house. It shall attract new investors as well as new and premium speculators.
Fundamentals of the company are strong enough and it will make new highs in profits as shown in Financial Statements. Company shall enhance its product portfolio after April 2008. New products will be added in portfolio during the transit of Rahu in Capricorn. The sales team of the company shall work faster and smarter during the transit of Mars from Leo, approximately mid-days of June 2008.
Ganesha wishes Ranbaxy Laboratories Ltd for enhancement in its price projection and investors shall get bigger benefits in forthcoming year.
The Ganeshaspeaks Team